en

PRODUCT DETAIL

Bloxazoc 25 mg tablety s predĺženým uvoľňovaním

Code 6853B
MA number 58/0488/15-S
Product Form: tbl plg 98x25 mg (blis.PVC/PE/PVDC/Al)
MA Status: D - Marketing Authorisation valid for an unlimited period
Type of procedure: Decentralised
MAH, country: KRKA, d.d., Novo mesto, Slovenia
Therapeutic Class: 58 - HYPOTENSIVA
ATC:
C CARDIOVASCULAR SYSTEM
C07 BETA BLOCKING AGENTS
C07A BETA BLOCKING AGENTS
C07AB Beta blocking agents, selective
C07AB02 Metoprolol
Shelf life: 36
Route of admin.: Oral use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 03.12.2015
Pediatric indication: Yes
Pediatric posology: Yes
PIL: PIL_Bloxazoc 25 mg_tbl plg_11/2021.pdf  
SPC: SPC_Bloxazoc 25 mg_tbl plg_11/2021.pdf  
Safety feature Yes
Data update: 25.11.2021
eu-flag.png sk-flag.png